Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Petrolatum
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Turn Therapeutics Receives Authorization to Commence Human Trial for COVID-19 Therapeutic Candidate
Details : Hexagen contains broad-spectrum, liquid antimicrobials with strong antiviral activity suspended in petrolatum. The trial will assess Hexagen’s ability to prevent COVID-19 infection in frontline workers when worn intranasally as an adjunct to personal p...
Brand Name : Hexagen
Molecule Type : Small molecule
Upfront Cash : Not Applicable
January 21, 2021
Lead Product(s) : Petrolatum
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?